Simoa Technology Platform Expands Into New Market
Quanterix Corporation's HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration in South Korea.
Category: Dementias & Alzheimer’s
Dementias & Alzheimer’s
Latest
Dementias & Alzheimer’s
Latest
Video Game Test May Be as Effective as Blood Tests for Alzheimer’s Early Detection
A video game test may help detect Alzheimer's years before symptoms appear, offering a non-invasive alternative to blood tests.
Dementias & Alzheimer’s
Latest
Mouth Bacteria May Give Window into Future Brain Function
Research suggests that mouth bacteria may influence memory and cognitive function, some promoting brain health while others risk Alzheimer’s.
Breakthrough Device Designation Granted to pTau 217 Blood Test for Alzheimer’s Detection
Spear Bio’s pTau 217 blood test, a less-invasive solution for early Alzheimer’s diagnosis, received an FDA Breakthrough Device Designation.
Read More
Structure of Huntington’s Disease Protein Clumps Identified
Researchers have visualized the atomic-level structure of protein clumps linked to Huntington’s disease, paving the way for diagnostic tools.
Read More
Alpha-Synuclein: Adding Precision to Neurodegenerative Testing
This episode of Clinical Lab Chat covers the how and why of making precise clinical diagnosis of neurodegenerative diseases.
Read More
Universities Collaborate on Validating Blood Test for Early Alzheimer’s Detection
Two universities are conducting a validation study on a blood test designed to detect early neurodegeneration in Alzheimer’s disease.
Read More
How a Skin Biopsy Can Evaluate Synucleinopathies
A new study demonstrates the clinical utility of a skin biopsy diagnostic tool in improving care for those with neurodegenerative diseases.
Read More
New Blood Test Biomarker Could Detect Dementia Risk Earlier and More Cost-Effectively
Researchers identified a promising blood biomarker for detecting vascular contributions to cognitive impairment and dementia.
Read More
Preparing Your Lab for Blood-Based Alzheimer’s Disease Testing
Blood-based diagnostics for Alzheimer’s disease and other neurological conditions could be here sooner than you think.
Read More
Researchers Explore Reliable Ways to Diagnose Alzheimer’s
Researchers explored how combining CSF analysis and amyloid PET imaging can improve the accuracy and efficiency of Alzheimer’s diagnosis.
Read More
VeraBIND Tau Assay for Alzheimer’s Detection Gets Positive Study Feedback
Study results were revealed for the VeraBIND Tau assay diagnostic test designed to detect active Alzheimer’s disease pathology.
Read More
Finger-Prick Blood Test Could Revolutionize Alzheimer’s Detection
A new capillary blood test offers a simple, mail-in method to detect Alzheimer’s biomarkers, paving the way for accessible global testing.
Read More
Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read More
Veravas and Phanes Biotech Partner to Develop Alzheimer’s Tau Pathology Test
Veravas and Phanes Biotech are collaborating to create a blood test using VeraBIND technology to detect Alzheimer’s tau pathology early.
Read More
Roche Presents New Alzheimer’s Disease Diagnostic Data
Roche announced the Elecsys Amyloid Plasma Panel shows promising results in accurately ruling out amyloid pathology in Alzheimer’s disease.
Read More
Olfactory Loss Linked to 100-Plus Diseases
Researchers have found a significant link between olfactory loss in 139 medical conditions, highlighting the role of smell plays.
Read More
New Multi-Marker Blood Test Enhances Alzheimer’s Detection
Lucent Diagnostics launched a blood test using five Alzheimer’s-related biomarkers to improve detection accuracy and reduce invasive testing.
Read More